David Roh, MD
Neurocritical Care · New York, NYNPI 1811214372
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,920 of the $2,827 with a category attached, or 67.9%. Instrumentation Laboratory Company accounts for 67.9% of it on its own, with 3 other manufacturers making up the rest. 2024 is the largest year on record at $2,104, 8.6 times the $246 reported in 2019. Among neurocritical care clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $117.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Instrumentation Laboratory Company$2K
- UCB, Inc.$812
- Medivance, Inc.$63
- Edwards Lifesciences$32
Across 3 payments — averaging $32,343 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$97K
What the payments were for
- Speaking & faculty fees$1,92068%
- Food & beverage$90732%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Instrumentation Laboratory Company | 1 | $1,920 |
| UCB, Inc. | 21 | $812 |
| Medivance, Inc. | 1 | $63 |
| Edwards Lifesciences | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Briviact$125
How this compares
$2,827 in reported general payments places this provider in the 90th percentile of 39 neurocritical care providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurocritical care in New York
- Neha DangayachNew York$1K
- Jan ClaassenNew York$1K
- Soojin ParkNew York$942
- Sachin AgarwalNew York$937
- Ariane LewisNew York$883
- Shivani GhoshalNew York$790
- Kara MelmedNew York$351
- Judy Ch'angNew York$255
- John LiangNew York$177
- Ting ZhouNew York$117
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.